Daniel Kirby

55 papers receiving 2.7k citations

Daniel Kirby's Hit Papers

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults 2014 · 557 citations
5570+4+8Years since publication100200300400500

Peers

Daniel Kirby
Comparison fields: 5 of 143
  • Pharmaceutical Science 355
  • Behavioral Neuroscience 153
  • Immunology 660
  • Epidemiology 646
  • Microbiology 108
Replace Craig W. Roberts with:
Craig W. Roberts United Kingdom
James M. Brewer United Kingdom
Jorge Pedrosa Portugal
Kevin O. Kisich United States
Jun Kunisawa Japan
Daniela Verthelyi United States
Mark A. Suckow United States
Patrick J. Tighe United Kingdom
H. N. Newman United Kingdom
David A. Hunstad United States
Daniel Kirby relative to Craig W. Roberts United Kingdom Craig W. Roberts's profile →
Citations per field
00.5×5.5×
Craig W. Roberts · 1×
Citations per year

Countries citing papers authored by Daniel Kirby

Since Specialization
Citations

This map shows the geographic impact of Daniel Kirby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Kirby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Kirby more than expected).

Fields of papers citing papers by Daniel Kirby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Kirby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Kirby. The network helps show where Daniel Kirby may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Kirby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Kirby Line = papers co-authored together Daniel Kirby links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Hit paper breakdown →
2014557
2 2005287
3 2008270
4 2016149
5 2002140
6 200991
7 199775
8 201269
9 200667
10 201766
11 200264
12 199459
13 201157
14 202255
15 200855
16 201049
17 201243
18 201242
19 201139
20 202034

About Daniel Kirby

Daniel Kirby is a scholar working on Molecular Biology, Pharmaceutical Science, Immunology, Biomedical Engineering and Pediatrics, Perinatology and Child Health, having authored 57 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (10 papers), Immunotherapy and Immune Responses (10 papers), Drug Solubulity and Delivery Systems (8 papers), Lipid Membrane Structure and Behavior (7 papers), Pharmaceutical studies and practices (6 papers), Advanced Drug Delivery Systems (6 papers), Microfluidic and Capillary Electrophoresis Applications (5 papers) and Immune Response and Inflammation (5 papers). The work is most often cited by research in Pharmaceutical Science (355 citations), Behavioral Neuroscience (153 citations), Immunology (660 citations), Epidemiology (646 citations) and Microbiology (108 citations). Daniel Kirby has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Yvonne Perrie, Afzal R. Mohammed, Vincent W. Bramwell, Else Marie Agger, Peter Andersen, Sarah E. McNeil, Ida Rosenkrands, Dennis Christensen, A. Vangala and Jesper Rømhild Davidsen. Their work appears in journals such as Pharmaceutics, International Journal of Pharmaceutics, Journal of Controlled Release, Journal of Pharmacy and Pharmacology and European Journal of Pharmaceutics and Biopharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact